This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech medical diagnosis

Annalise Donelon's Brain Tumor Diagnosis

Analysis based on 8 articles · First reported Jun 07, 2026 · Last updated Jun 08, 2026

Sentiment
-50
Attention
2
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

This event highlights the challenges in accessing advanced medical treatments within national healthcare systems like the United Kingdom — National Health Service, potentially increasing demand for private and international healthcare services. It also underscores the need for increased investment in clinical trials and research within the biotechnology and pharmaceutical industries to develop new therapies for conditions like brain tumors.

healthcare biotechnology

Annalise Donelon, a 20-year-old chemical engineering student at Newcastle University, was diagnosed with a 5cm high-grade cancerous brain tumor after her persistent headaches were initially misdiagnosed as a B12 deficiency or exam stress. She underwent an 11-hour craniotomy at Salford Royal Hospital to remove most of the tumor, followed by six weeks of radiotherapy. Due to the uncertainty of the tumor's eradication and the unavailability of certain advanced treatments on the United Kingdom — National Health Service, Annalise Donelon and her family are fundraising £100,000 for international treatments, including molecular profiling in London, targeted molecular therapy in France, and immunotherapy in Germany. The Brain_Tumour_Charity has highlighted the urgent need for more clinical trials in the United Kingdom to provide accessible treatments. Annalise Donelon plans to switch her studies to biochemistry to contribute to research in genomic medicine.

per
Annalise Donelon was diagnosed with a cancerous brain tumor after experiencing severe headaches, leading to surgery, radiotherapy, and a search for international treatments. Her condition has significantly impacted her life and academic pursuits.
Importance 100.0 Sentiment -70.0
govactor
The United Kingdom — National Health Service is highlighted for not offering certain advanced immunotherapy treatments that Annalise Donelon's family is seeking internationally, prompting calls for more UK-based clinical trials.
Importance 50.0 Sentiment -20.0
ngo
The Brain Tumour Charity advocates for better access to treatments and more clinical trials in the United Kingdom, supporting patients like Annalise Donelon.
Importance 30.0 Sentiment 20.0
cnt
The United Kingdom's healthcare system, specifically the United Kingdom — National Health Service, is noted for the unavailability of certain advanced cancer treatments, leading patients to seek options abroad.
Importance 30.0 Sentiment 0.0
cnt
Annalise Donelon is due to begin immunotherapy treatment in Germany, which is not yet available on the United Kingdom — National Health Service.
Importance 20.0 Sentiment 0.0
cnt
Annalise Donelon visited a hospital in France for targeted molecular therapy.
Importance 10.0 Sentiment 0.0
United Kingdom allies Germany The United Kingdom considers Germany a vital strategic and economic partner in Europe, sharing defense commitments throu
United Kingdom allies France The United Kingdom relies on its alliance with France for regional security, joint naval operations, and nuclear defense
Germany allies France Germany views France as an indispensable European and NATO ally, despite experiencing significant friction and deadlock
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.